Programmed Death Receptor-1-directed Antibody Interactions

Programmed Death Receptor-1 Blocking Antibody

Endometrial Neoplasms

<section class="Section" data-sectioncode="34089-3"><a name="ID_152fb665-21cc-43b3-b988-d6ada42079b6"></a><a name="section-8"></a><p></p><h1>11 DESCRIPTION </h1><p class="First">Dostarlimab-gxly is a programmed death receptor-1 (PD-1)–blocking IgG<span class="Sub">4</span> humanized monoclonal antibody. Dostarlimab‑gxly is produced in Chinese hamster ovary cells and has a calculated molecular weight of about 144 kDa.</p><p>JEMPERLI (dostarlimab-gxly) injection is a sterile, clear to slightly opalescent, colorless to yellow solution essentially free from visible particles. It is supplied as single-dose vials.</p><p>Each vial contains 500 mg of JEMPERLI in 10 mL of solution with a pH of 6. Each mL of solution contains 50 mg of dostarlimab-gxly, citric acid monohydrate (0.48 mg), L-arginine hydrochloride (21.07 mg), polysorbate 80 (0.2 mg), sodium chloride (1.81 mg), trisodium citrate dihydrate (6.68 mg), and Water for Injection, USP.</p></section>

Jemperli

dostarlimab

dostarlimab-gxly

10 ML dostarlimab-gxly 50 MG/ML Injection

10 ML dostarlimab-gxly 50 MG/ML Injection [Jemperli]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Submit MSL Request 

Pharmacy List 

Coverage Authorization Request 

Coverage Authorization Appeals 

Letter of Medical Necessity 

Jemperli Service Request Form 

Together with GSK Oncology - HCP Portal 

Enroll in Patient Savings Program 

GSK Patient Assistance Program Eligibility & Enrollment 

How To Order Jemperli

Together with GSK Oncology Brochure 

Together with GSK Oncology Patient Co-pay Brochure

Other HCP Resources 

About Jemperli 

Side Effects

Taking Jemperli 

Instructions For Use: Endometrial Cancer 

Prescribing Information

Medication Guide 